※ 引述《gibbs1286 (學無止境是國關)》之銘言：
: https://reurl.cc/4a88LV
: 路透社報導
: Fosun-BioNTech COVID-19 vaccine completes China regulator review - media
: SHANGHAI, July 15 (Reuters) - Chinese regulators have completed an expert
: review of a COVID-19 mRNA vaccine developed by Germany's BioNTech (22UAy.DE)
: and Fosun Pharma (600196.SS) and the shot is in the administration review
: stage, Caixin reported, citing the Chinese company.
那這不就 糟糕了
之前不誠實中才說 中國在打得我們不敢用耶
現在大陸要打BNT了
這樣台灣是不是要 BNT NO
國內疫苗用量吃緊，近日地方政府紛紛祭出自救措施，中國大陸國台辦也提出，上海復星
醫藥集團有意願將其代理的德國BNT疫苗給予台灣民眾。對此，中央流行疫情指揮官陳時
中今天透露，疫苗是救命的，是有它的風險在，審查上面也要很嚴謹，「他們（中國）沒
在打的我們有點興趣，他們在打的，我們不敢用。」
CDC也要轉彎惹ㄇ
嘻嘻
: China hasn't approved any COVID-19 vaccine developed overseas but
: greenlighted several domestic brands, administering 1.4 billion doses so far,
: or two-fifths of the global total of 3.47 billion doses.
: BioNTech Chief Executive Ugur Sahin said in April he expected its COVID-19
: vaccine would win approval from the Chinese authorities "by June at the
: latest."
: BioNTech and Fosun did not immediately reply to Reuters' requests for comment.
: The vaccine is on track to begin trial production in China at the end of
: August, Caixin cited Fosun Pharma chairman Wu Yifang as saying at a
: shareholders' meeting on Wednesday.
: It said the vaccine would be used as a booster shot for people who have
: received vaccines using inactivated viruses.
: These are vaccines that use a coronavirus that cannot replicate in human
: cells and include Sinovac's (SVA.O) COVID-19 shot.
: 簡單來說就是中國政府對BNT疫苗已經通過專家審查，進入行政審查並預計作為那些打過
: 科興、國藥的人的第三針加強劑，然後八月底復星在中國開始試生產BNT疫苗
: 復星：反正你最後都還是要打BNT的，為什麼不一開始就打BNT呢，ㄏㄏ
: 好險郭董跟GG已經完成簽約了，不然再過幾個月復星真的可能不賣台灣了....因為優先供給中國國內
: 只是這算是側面說中國國產疫苗算是不成功嗎?因為最後還是要打國外的疫苗XD